Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type 1 selected

Type

Guidance programme 1 selected

Guidance programme

Area of interest

Showing 1 to 10 of 918

TitleReference numberPublishedLast updated
Pembrolizumab with chemoradiotherapy for untreated locally advanced cervical cancerTA1177
Cemiplimab for treating recurrent or metastatic cervical cancer that has progressed on or after platinum-based chemotherapyTA1174
Glycopyrronium bromide cream for treating severe primary axillary hyperhidrosisTA1175
Teplizumab for delaying the onset of stage 3 type 1 diabetes in people 8 years and over with stage 2 type 1 diabetesTA1176
Pirtobrutinib for treating relapsed or refractory chronic lymphocytic leukaemia after a BTK inhibitorTA1173
Atogepant for treating migraineTA1172
Mirvetuximab soravtansine for treating folate receptor-alpha-positive platinum-resistant epithelial ovarian, fallopian tube or primary peritoneal cancerTA1169
Daratumumab with bortezomib, lenalidomide and dexamethasone for untreated multiple myeloma when a stem cell transplant is unsuitableTA1170
Seladelpar for previously treated primary biliary cholangitisTA1171
Bempedoic acid with ezetimibe for treating primary hypercholesterolaemia or mixed dyslipidaemiaTA694

Results per page

  1. 10
  2. 25
  3. 50
  4. All